Coronavirus mutations in New York, California raise concerns Science | In-depth reporting on science and technology DW

As health authorities began to follow positive COVID-19 cases more closely – ie to genetically examine the test results – they also found more and more mutations.

Most of the mutations are insignificant. But there are some variants that researchers and officials are concerned about, in part because they are more contagious and because existing vaccines may be less effective at protecting against them.

A border checkpoint on the Czech-German border

No more freedom of movement. Some countries try to stop the spread of mutations by closing borders.

In addition to the variants identified in Britain, South Africa and Brazil, there are two other variants that are of concern in the United States, which have apparently developed there.

Fast distribution

In November, researchers first noticed a mutation in New York City called B.1.526. Since then, this variant has spread rapidly in the metropolis and in the state. By mid-February, it was detected in 12% of all samples in New York generated.

This variant has also appeared in other countries such as Denmark.

A woman with a face mask jogs in front of the Golden Gate Bridge in the background

The California variant, CAL.20, is thought to be more contagious than the original virus, but not as dangerous as the British variant.

The so-called California variant, which was first detected in July 2020, also spread rapidly. Meanwhile, the two similar species, B.1.427 and B.1.429, of the California variant can be found in about a quarter of the gene-generated samples in California.

What do we know about the two American variants?

So far we do not have thorough reliable data on these variants. The California variant, CAL.20C, is said to be more contagious than the original SARS-CoV-2 virus. In swabs taken from infected individuals, it was found that the virus load in the samples was approximately doubled. But it is less contagious than the British mutant B.1.1.7, which has now been detected in a large number of countries, including Germany. The existing vaccines are thought to be somewhat less effective against the California virus variant, but still sufficient to protect patients from a severe course of COVID-19.

The New York virus variant, B.1.526, is similar to the South African variant, B.1.351, which has already been detected in more than 40 countries, and also shows similarity to the Brazilian variants, P.1 and P.2, which has been detected in more than 20 countries, most recently in the United Kingdom.

It is still unclear whether the New York variant is more contagious or dangerous, and whether existing vaccines are still effective against this variant.

New software helps with the search

Finding the various variants is only possible if you know what to look for. Although we now know the SARS-CoV-2 genome, the virus is 29,903 nucleotides long, which is far too long to quickly identify which variants could make it more contagious among the 611,000 genomes now stored in the GISAID database. word.

The mutations were found using new software called Variant Database (VDB) developed at the California Institute of Technology in Pasadena, by a team led by Pamela Bjorkman. It focuses on changes in the vein protein.

A man gets a dip test in Johannesburg

A mutation called E484K has been found in both the South African and the Brazilian variant.

The potentially dangerous mutation E484K, present in B.1.351 and P.1, alters the receptor binding domain of the vein protein, and this is where the antibodies attack with the strongest neutralizing effect.

Worrying, but not for panic

The tip of the vein protein is also changed into the New York variant. Understandably, this has caused some concern, Columbia University epidemiologist Wafaa El-Sadr told German public broadcaster ARD. “These changes could lead to the peak protein attaching itself better. Or that the virus could reproduce faster. Or that it could not be fought by the antibodies through our vaccines,” he said.

Until detailed and robust data on the American variant is available, these observations remain speculative and you do not have to panic, said Dave Chokshi, commissioner of the Department of Health and Mental Hygiene in New York. There is still no evidence that it spreads faster, whether it makes people sicker or whether it reduces the effectiveness of the vaccine, he said.

This article has been translated from German.

.Source